Skip to main content
Clinical Trials/CTRI/2019/04/018430
CTRI/2019/04/018430
Recruiting
未知

Genotype phenotype correlation in Indian Patientswith Congenital Adrenal Hyperplasia due to 21-α hydroxylase deficiency.

A0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E250- Congenital adrenogenital disordersassociated with enzyme deficiency
Sponsor
A
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
A

Eligibility Criteria

Inclusion Criteria

  • Patients with clinically and biochemically diagnosed Congenital adrenal hyperplasia due to 21\-α Hydroxylase deficiency.

Exclusion Criteria

  • Patientswith congenital adrenal hyperplasiahaving clinical and biochemical diagnosis of 11 Beta Hydroxylase deficiency or 3\-Beta hydroxylase deficiency.

Outcomes

Primary Outcomes

Not specified

Similar Trials